HSP70及TNF基因与新疆和田地区维吾尔族自然长寿的关联研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
背景:炎症是组织应对创伤或感染所引发的一系列反应,是细胞和分子之间复杂的相互作用,最终使机体恢复生理平衡和促进组织修复,个体对感染和创伤的不同反应是由基因决定的。最近的研究中认为衰老伴随着慢性低水平的炎症反应状态,血清炎症介质增加到正常值的2-4倍可以清楚地表明这一点。这种慢性持续性低水平的炎症反应状态有多种因素的参与,其中慢性抗原负荷似乎发挥了最重要的作用,通过激活巨噬细胞和淋巴细胞而影响免疫系统,这种“前炎症反应状态”与遗传背景相互作用,有可能触发多种年龄相关性炎症性疾病,如动脉粥样硬化等的发病。因此,分析免疫反应中关键因子的基因的多态性可能明确年龄相关性炎症性疾病如动脉粥样硬化的病理生理机制。另一方面,百岁老人的特点是明显的推迟或免于罹患年龄相关性疾病,百岁老人后代存活至100年的可能性较高,而易于罹患年龄相关性疾病,如心血管疾病(CVD)和具有心血管病危险因素者长期存活的可能性较低,而且与心血管疾病密切关联的基因可能在长寿中发挥相反的作用。因此,对百岁老人的研究可以用来揭示与炎症反应密切相关的基因在成功和不成功的衰老中发挥的作用。
     百岁老人代表着寿命的极端情况,是进行人类长寿研究最佳的人群。新疆和田地区维吾尔族百岁老人数量和相对比例均高于全国平均水平,是世界四大长寿区之一。并且由于环境、生活特点及风俗习惯,形成了特殊的遗传隔离群,因此被称之为自然长寿人群,是长寿遗传学研究的难得资源。
     长寿的遗传学研究方法,除常用的比较长寿者和对照人群之间单个多态性基因型分布的研究方法外,连锁不平衡和单倍型分析逐渐成为研究寿命这一受多基因及基因环境相互作用共同控制的复杂表型更为有效的遗传研究方法,对关联分析尤其复杂疾病的关联研究极为有用。
     目的:探索HSP70基因的三种常见的遗传变异包括A1267G(rs1061581,外显子1),G190C(rs1043618,5′端非编码区)和T2437C(rs2227956,外显子2)的多态性对自然长寿的影响。并探讨TNFβ基因外显子+252G/A和TNFα基因启动子区-863C/A以及TNFα基因启动子区-308G/A多态性并分析其单倍型与新疆和田地区维吾尔族自然长寿之间的关系。
     方法:以新疆和田地区191名年龄90岁以上的健康维吾尔族自然长寿个体为研究对象,以53名地域、民族、性别相匹配的无长寿家族史,在75岁前自然死亡的个体为对照,进行流行病学调查。测定身高、体重、收缩压(systolic blood pressure,SBP)和舒张压(diastolic blood pressure,DBP)、总胆固醇(total cholesterol,TC)、甘油三酯(triglyceride,TG)、高密度脂蛋白胆固醇(high density lipoprotein cholesterol,HDL-C)、低密度脂蛋白胆固醇(low density lipoprotein cholesterol,LDL-C)、载脂蛋白A(apolipoprotein A,ApoA)和血糖(blood glucose,BG)水平。提取白细胞基因组DNA,分别采用PCR(polymerase chain reaction)、PCR-限制片段长度多态性(PCR-restriction fragment length polymorphism,PCR-RFLP)和PCR直接测序等技术对HSP70基因A1267G、G190C、T2437C多态性和TNFβ基因+252G/A以及TNFα基因启动子区-308G/A、-863C/A多态性进行基因分型,并进行单倍型分析。
     结果:我们研究了热休克蛋白70(HSP70)家族的三个等位基因(A1267G,G190C和T2437C)与新疆和田地区维吾尔族自然长寿的关联。这是一项以191例90岁以上健康的长寿老人和53例同地区的自然死亡年龄在65-70岁个体作对照组的病例对照研究。分析采用EH/EH+程序,用MDR软件分析基因和基因的相互作用。两组中所有的研究变量符合Hardy-Weinberg平衡。所有等位基因的基因型和等位基因频率在长寿组和对照组间的分布无显着差异,与此相反,单倍型分析表明,单倍型A-C-G(按A1267G,T2437C和G190C顺序)和A-T-C在长寿组的分布频率较对照组增高,差异具有显著性(P=0.026和0.017),并分别表现出3.46和4.51倍使寿命增加的趋势。单倍型的结果由交互作用分析进一步加强,G190C和T2437C对促进长寿显示出更为优化的相互作用。综上,我们的研究结果表明,热休克蛋白70家族常见的基因变异在维吾尔族长寿中发挥作用。
     TNFβ基因外显子+252G/A,TNFα基因启动子-308G/A和TNFα启动子区-863C/A多态性各等位基因、基因型及单倍型与新疆和田维吾尔族自然长寿无关。基因多态性分布不仅存在种族差异,在同一民族之间还存在地域差异。在新疆和田维吾尔族中,存在长期遗传隔离所造成的TNFβ基因外显子+252G/A,TNFα基因启动子-308G/A和TNFα启动子区-863C/A多态性间的特有的分布特点。将3个多态性同时纳入单倍型分析时,在长寿组和对照组均有8种单倍型,分别是A-G-C、G-G-C、A-G-A、G-A-C、A-A-C、G-G-A、G-A-A、A-A-A其中5种为常见单倍型,两组中均以A-G-C为主要单倍型。但均未发现与长寿相关,且交互作用研究并未发现各位点间存在着相互作用。
     结论:1.HSP70基因多态性可能与长寿相关。热休克蛋白(HSP)三个多态性位点(+1267G/A,+190 G/C和+2437 T/C)的基因型和等位基因频率在长寿组和正常对照组间的差异。单倍型A-C-G和A-T-C(按A1267G,T2437C和G190C的顺序)具有使寿命更长的遗传倾向,而单倍型A-C-C具有截然相反的趋势。交互效应的分析结果表明G190C和T2437C位点间可能有很强的协同效应,从单倍体和其相互作用的结果看来,我们指出这两个基因型的遗传结构中具有一个突变等位基因(190G-2437C和190C-2437T)者更趋向长寿,而另外的突变组合(190C-2437C)不利于长寿。这可能表明这两个突变位点间存在着相互作用。
     2.对TNF基因多态性的研究显示,+252G/A,-308G/A和-863C/A 3个多态性位点基因型及等位基因的分布在长寿与对照组之间均无统计学差异。3个多态性不同基因型和单倍型在长寿组与对照组中的分布均无统计学差异,未发现具有交互作用的基因位点。
Backgroud.Inflammation is considered a response set by the tissues in response to injury elicited by trauma or infection.It is a complex network of molecular and cellular interactions that facilitates a return to physiological homeostasis and tissue repair.The individual response against infection and trauma is also determined by gene variability. Ageing is accompanied by chronic low-grade inflammation state clearly showed by 2-4-fold increase in serum levels of inflammatory mediators.A wide range of factors has been claimed to contribute to this state;however,the most important role seems to be played by the chronic antigenic stress,which affects immune system thorough out life with a progressive activation of macrophages and related cells.This pro-inflammatory status,interacting with the genetic background,potentially triggers the onset of age-related inflammatory diseases as atherosclerosis.Thus,the analysis of polymorphisms of the genes that are key nodes of the natural immunity response might clarify the patho-physiology of age-related inflammatory diseases as atherosclerosis.On the other hand,centenarians are characterized by marked delay or escape from age-associated diseases that,on average,cause mortality at earlier ages.In addition,centenarian offspring have increased likelihood of surviving to 100 years and show a reduced prevalence of age-associated diseases,as cardiovascular disease(CVD) and less prevalence of cardiovascular risk factors.So,genes involved in CVD may play an opposite role in human longevity.Thus,the model of centenarians can be used to understand the role of these genes in successful and unsuccessful ageing.
     The centenarian,who represents the extremity of longevity,was the optimal population of researching the human longevity.The quantity and relative ratio of centenarian in Xinjiang Hetian were over the average level of whole country,so Hetian was classified as one of four longevity regions in the world.Furthermore,because of environment,living characteristics,customs and habits,the Uygur who lived in this region became genetic isolation population and belonged to the natural longevity.Thereby,they were the value resource of gendetic study about longevity.
     Besides the common methods which compared the genotype distribution of single polymorphism between the longevities and the controls,the genetic methods of longevity study include the linkage disequilibrium and haplotype analysis,which became increasingly the effective methods of studying the life-span that was the complex phenotype controlled by multiple genes and gene-environment interaction.The linkage disequilibrium and haplotype analysis were valuable to association analysis,especially the association study of complex diseases.
     Objectives:To investigate the association between polymorphisms(A1267G, G190C andT2437C) and their haplotype within heat shock protein(HSP) gene,as well as polymorphisms(+252G/A,-863C/A and-308G/A) and their haplotype within the tumor necrosis factor(TNF) gene,and natural longevity in Xinjiang Uygur population.
     Methods:191 healthy Uygur individuals over 90 years in Xinjiang Hetian were recruited.And 53 area-,nationality-,gender-matched individuals who had no longevity family history and died in their 75 years were studied as control subjects.Their height, weight,systolic blood pressure(SBP) and diastolic blood pressure(DBP),serum total cholesterol(TC),triglyceride(TG),high density lipoprotein cholesterol(HDL-C),low density lipoprotein cholesterol(LDL-C),apolipoprotein A(ApoA) and blood glucose(BG) were measured.Genome DNA was extracted from white blood cells.Using polymerase chain reaction(PCR),PCR-restriction fragment length polymorphism(PCR-RFLP) and direct sequencing technique,we tested the polymorphisms of the polymorphisms of A1267G、G190C and T2437C within H SP70 gene,the polymorphisms of+252G/A within TNFβand the polymorphisms of -308G/A and-863C/A within TNFαgene,moreover, performed the linkage disequilibrium and haplotype analysis.
     Results:We investigate the association of three variants(A1267G,G190C and T2437C) in heat shock protein 70(Hsp70) family with natural longevity in a Xinjiang Hetian Uygur population.A case-control study was conducted in 191 healthy individuals aged above 90 years,and 53 naturally-died persons aged 65-70 years.Promoter activity was evaluated by luciferase reporter assays.Data were analyzed using EH/EH+ program for hypotype prediction and MDR software for gene-gene interaction.All studied variants satisfied Hardy-Weinberg equilibrium in each group.In single-locus analysis,no significant differences were found between longevities and controls in the genotype/allele distributions of all variants.In contrast,haplotype analysis indicated that haplotypes A-C-G(in order of A1267G,T2437C and G190C) and A-T-C were more prevalent in longevities than controls(P=0.026 and 0.017),and conferred a 3.46- and 4.51-fold increased tendency for longevity,respectively.Haplotype results were further strengthened by interaction analysis,suggesting an optimal model with G190C and T2437C exerting an interacting effect on longevity.Taken together,our findings suggested that common genetic variants in Hsp70 family might contribute interactively to longevity in Uygur.
     The variants(+252G/A,-308G/A and -863C/A) in TNF gene,including alleles, genotype and haplotype show no association with longevity.The gene polymorphism exist not only in ethinity but also in area.Special charactoristics exist in polymorphism of +252G/A,-308G/A and -863C/A with Hetian Uygur.There are 8 haplotypes of the TNF gene,that is,A-G-C、G-G-C、A-G-A、G-A-C、A-A-C、G-G-A、G-A-A and A-A-A.The most common is A-G-C.There is no association with longevity.
     Conclusions:AA genotype of promoter-2437G/A polymorphism within HSP gene was the advantageous factor of longevity.A-C-G and A-C-T haplotype of A1267G,T2437C和G190C polymorphisms was the beneficial factor of longevity.. Furthermore,there was the extensive linkage among G190C and T2437C,resulted from long-term genetic isolation in Uygur in Xinjiang Hetian.
     There was no correlation between the alleics,genotypes and haplotypes of polymorphisms within TNF gene,Furthermore,there was no linkage between+252G/A, -308G/A and -863C/A,resulted from long-term genetic isolation in Uygur in Xinjiang Hetian.And the result of-863C/A polymorphism suggested the base sequences of this polymorphism had race specificity
引文
[1]Mitchell,R.N.,Cotran,R.S.,2003.Acute and chronic inflammation.In:In Robbins Basic Pathology,Saunderrs,Philadelphia,USA.Nabel,E.G.,2003.Cardiovascular disease.N.Engl.J.Med.349,60-72
    [2]Feghali,C.A.,Wright,T.M.,1997.Cytokines in acute and chronic inflammation.Front Biosci.2,d12-d26
    [3]Anderson,J.L.,2005.Infection,antibiotics,and atherothrombosis-end of the road or new beginnings? N.Engl.J.Med.352,1706-1709
    [4]Imahara,S.D.,O'Keefe,G.E.,2004.Genetic determinants of the inflammatory response.Curr.Opin.Crit.Care 10,318-324
    [5]Hollegaard,M.V.,Bidwell,J.L.,2006.Cytokine gene polymorphism in human disease:on-line databases.Genes Immun.S37,269-276
    [6]Licastro,F.,Candore,G,Lio,D.,Porcellini,E.,Colonna-Romano,G,Franceschi,C,Caruso,C,2005.Innate immunity and inflammation in ageing:a key for understanding age-related diseases.Immun.Ageing 2,8
    [7]Krabbe,K.S.,Pederesen,M.,Bruunsgaard,H.,2004.Inflammatory mediators in the elderly.Exp.Gerontol.39,687-699
    [8]Franceschi,C,Bonafe',M.,Valensin,S.,et al,2000a.Inflamm-aging.An evolutionary perspective on immunosenescence.Ann.N.Y.Acad.Sci.908,244-254
    [9]De Martinis,M.,Franceschi,C,Monti,D.,et al,2005.Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity.FEBS Lett.579,2035-2039
    [10]Candore,G,Colonna-Romano,G,Balistreri,C.R.,et al,2006a.Biology of longevity:role of the innate immune system.Rejuvenation Res.9,143-148
    [11]Troen,B.R.,2003.The biology of aging.Mt.Sinai.J.Med.70,3-22
    [12]Roush,W.,1996.Live long and prosper? Science 273,42-44
    [13]Wilmoth,J.R.,Deegan,L.J.,Lundstrom,H.,et al,2000.Increase of maximum life-span in Sweden,1861-1999.Science 289,2366-2368
    [14]Finch,C.E.,Crimmins,E.M.,2004.Inflammatory exposure and historical changes in human life-spans.Science 305,1736-1739
    [15]Franceschi,C,Monti,D.,Sansoni,P.,et al,1995.The immunology of exceptional individuals:the lesson of centenarians.Immunol.Today 16,12-16
    [16]Franceschi,C,Bonafe,M.,2003.Centenarians as a model for healthy aging.Biochem.Soc.Trans.31,457-461
    [17]Caruso,C,Candore,G,Colonna-Romano,G et al,2005.Inflammation and life-span.Science 307,208-209
    [18]Franceschi,C,Olivieri,F.,Marchigiani,F.,et al,2005.Genes involved in immune response/inflammation,IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity:the lesson of centenarians.Mech.Ageing Dev.126,351-361
    [19]Rea,I.M.,Candore,G.,Cavallone,L.,et al,2006.In:Koen,V.(Ed.),Cytokine Gene Polymorphisms in Multifactorial Conditions.CRC Press,Florida,USA,pp.379-394
    [20]Terry,D.E,Wilcox,M.,McCormick,M.A.,et al,2003.Cardiovascular advantages among the offspring of centenarians.J.Gerontol.A Biol.Sci.Med.Sci.58,M425-M431
    [21]Blake,G.J.,Ridker,P.M.,2002.Inflammatory bio-markers and cardiovascular risk prediction.J.Intern.Med.252,283-294
    [22]Qiao,J.H.,Tripathi,J.,Mishra,N.,1997.Role of macrophage colony-stimulating factor in atherosclerosis:studies of osteopetrotic mice.Am.J.Pathol.150,1687-1699
    [23]Barabasi,A.L.,Oltvai,Z.N.,2004.Network biology:understanding the cell's functional organization.Nat.Rev.Genet.5,101-113
    [24]Sanceau,J.,Kaisho,T.,Hirano,T.et al,1995.Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1,NF kappa B,and Spl transcription factors.J.Biol.Chem.270,27920-27931
    [25]Libby,P.,2001.Current concepts of the acute coronary syndromes.Circulation 104,365-372
    [26]Andreotti,E,Porto,I.,Crea,E,et al,2002.Inflammatory gene polymorphisms and ischaemic heart disease:review of population association studies.Heart 87,107-112
    [27]Stephens,J.W.,Humphries,S.E.,2003.The molecular genetics of cardiovascular disease:clinical implications.J.Intern.Med.253,120-127
    [28]Balistreri,C.R.,Candore,G,Colonna-Romano,G,et al,2004.Role of Toll-like receptor 4 in acute myocardial infarction and longevity.JAMA 292,2339-2340
    [29]Lio,D.,Candore,G,Crivello,A.,et al,2004.Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing:genetic background of male centenarians is protective against coronary heart disease.J.Med.Genet.41(10),790-794
    [30]List.,F.,Candore,G,Lio,D.,et al,2005.Association between C1019T polymorphism of connexin37 and acute myocardial infarction:a study in patients from Sicily.Int.J.Cardiol.102,269-271
    [31]Grimaldi,M.P.,Candore,G,Vasto,S.,et al,2006.Role of the pyrin M694V(A2080G)allele in acute myocardial infarction S.Vasto et al./ Mechanisms of Ageing and Development 128(2007)83-91
    [32]Candore,G,Vasto,S.,Colonna-Romano,G,et al,2006c.Cytokine gene polymorphisms and atherosclerosis.In:Koen,V(Ed.),Cytokine Gene Polymorphisms in Multifactorial Conditions.CRC Press,Florida,USA,pp.363-378
    [33]Jeong,H.,Tombor,B.,Albert,R.,et al,2000.The large-scale organization of metabolic networks.Nature 407,651-654
    [34]Janeway Jr.,C.A.,2001.How the immune system protects the host from infection.Microbes Infect.3,1167-1171
    [35]Capri,M.,Salvioli,S.,Sevivi.F.et al,2002.Toll-like receptor 4 polymorphisms and atherogenesis.N.Engl.J.Med.347,185-192
    [36]Dubois,R.N.,Abramson,S.B.,Crofford,L.et al,1998.Cyclooxygenase in biology and disease.FASEB J.12,1063-1073
    [37]Schroder,N.W.,Schumann,R.R.,2005.Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease.Lancet Infect.Dis.5,156-164
    [38]Dubois,R.N.,Abramson,S.B.,Crofford,L.,et al,1998.Cyclooxygenase in biology and disease.FASEB J.12,1063-1073
    [39]Jala,V.R.,Haribabu,B.,2004.Leukotrienes and atherosclerosis:new roles for old mediators.Trends Immunol.25,315-322
    [40]Stoll,L.L.,Denning,G.M.,Weintraub,N.L.,2004.Potential role of endotoxin as a proinflammatory mediator of atherosclerosis.Arterioscler.Thromb.Vase.Biol.24,2227-2236
    [41]Desvarieux,M.,Demmer,R.T.,Rundek,T,et al,2005.Periodontal microbiota and carotid intima-media thickness:the Oral Infections and Vascular Disease Epidemiology Study(INVEST).Circulation 111,576-582
    [42]Crimmins,E.M.,Finch,C.E.,2006.Infection,inflammation,height and longevity.PNAS 1003,498-503
    [43]Arroyo-Espliguero,R.,Avanzas,P.,Jeffery,S.,et al,2004.CD 14 and toll-like receptor 4:a link between infection and acute coronary events? Heart 90,983-988
    [44]van der Graaf,C,Kullberg,B.J.,Joosten,L.,et al,2005.Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism.Cytokine 30,264-268
    [45]Lio,D.,Caruso,C,2006.IL-10,genetic polymorphism and its relevance to age-related diseases.In:Marincola,F.M.(Ed.),Interleukin-10.Eureka.com,Georgetown,Texas,USA,pp.93-106
    [46]Cipollone,F.,Fazia,M.L.,2006.COX-2 and atherosclerosis.J.Cardiovasc.Pharmacol.47S1.S26-S36
    [47]Vane,J.R.,Bakhle,Y.S.,Botting,R.M.,1998.Cyclooxygenases 1 and 2.Annu.Rev.Pharmacol.Toxicol.38,97-120
    [48]Smith,W.L.,DeWitt,D.L.,Garavito,R.M.,2000.Cyclooxygenases:structural,cellular,and molecular biology.Annu.Rev.Biochem.69,145-182
    [49]Lusis,A.J.,Fogelman,A.M.,Fonarow,GC,2004.Genetic basis of atherosclerosis:part I:new genes and pathways.Circulation 110,1868-1873
    [50]Dwyer,J.H.,Allayee,H.,Dwyer,K.M.et al,2004.Arachidonate 5-lipoxygenase promoter genotype,dietary arachidonic acid,and atherosclerosis.N.Engl.J.Med.350,29-37
    [51]Franceschi,C.,Bonafe,M.,Valensin,S.,2000b.Human immunosenescence:the prevailing of innate immunity,the failing of clonotypic immunity,and the filling of immunological space.Vaccine 18,1717-1720
    [52]Pawelec,G.,Ouyang,Q.,Colonna-Romano,G,et al,2002.Is human immunosenescence clinically relevant? Looking for immunological risk phenotypes.Trends Immunol.23,330-332
    [53]Pawelec,G.,Akbar,A.,Caruso,C,et al,2004.Is immunosenescence infectious? Trends Immunol.25,406-410
    [54]Pawelec,G.,Akbar,A.,Caruso,C,et al,2005.Human immunosenescence:is it infectious? Immunol.Rev.205,257-268
    [55]Edited by vital statistics governmental department of State Statistics Bureau.Annual report forms of China vital statistics[M].Beijing:China statistics publishing company,1993:52
    [56]Wei J Gong,Kent G Golic.Loss of Hsp70 in Drosophila is pleiotropic,with effects on thermotolerance,recovery from heat shock,and neurodegeneration[J]Genetics,2006,172(1):275-286
    [57]Suzuki k,Sawa Y,Kagisaki k,et al.Reduction in myocardial apoptosis associated with overexpression of heat shock protein 70[J].Basic Res Cardiol,2000,95(5):397-403
    [58]Tanonaka K,Furuhama KI,Yoshida H,et al.Protective effect of heat shock protein 72 on contractile function of perfused failing heart[J].Am J Physiol Heart Circ Physiol,2001,281(1):H215-H222
    [59]Baba HA,Schmid C,Wilhelm MJ,et al.Inducible heat shock protein 70 in rat cardiac allograft and its inmmunohistochemical localization in cardiac myocytes[J].Transplanation,1997,64(7):1035-1040
    [60]Liossis SC.Overexpression of the heat shock protein70 enhances the TCR/CD3 and Fas/Apo-1/CD95 mediated apoptotic cell death in Jurkat T cell[J].J Immunol,1997,158(12):5668-5675
    [61]Srivastava PK.Interaction of heat shock proteins with peptides and antigen presenting cells:Chaperoning of the innate and adaptive immune Responses.Annu Rev Immunol,2002,20(1):395-425
    [62]Udono H,Srivastava PK.Comparison of tumor-specific immunogenicities of stress-induced proteins gp96,hsp90,and hsp70.J Immunol,1994,152:5398-5403.
    [63]Favatier F,Bomman L,Hightower LE,et al.Variation in lisp gene expression and HSP polymorphism:do they contribute to differential disease susceptibility and stress tolerance? Cell Stress Chaperones,1997,2:141-155
    [64]Milner CM,Campbell RD.Structure and expression of the MHC linked HSP70 genes[J].Immunogenetics,1990,329(4):242-251
    [65]Jalbout M,Bouaouina N,Gargouri J,et al.Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma[J].Cancer Lett,2003,193(1):75-81
    [66]Milner CM,Campbell RD.Polymorphic analysis of the three MHC linked HSP70 genes[J].Immunogenetics,1992,36(6):357-362
    [67]Favatier F,Bornman L,Hightower LE,et al.Variation in hsp gene expression and Hsp polymorphism:do they contribute to differential disease susceptibility and stress tolerance? Cell Stress Chap,1997,2:141-155
    [68]Mestiri Set Bouaouina N,Ahmed SB,al.Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2:susceptibility and prognostic implications in breast carcinoma.Cancer,2001,91:672-678
    [69]Jalbout M,Bouaouina N,Garqouri J,et al.Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma.Cancer Lett,2003,193:75-81
    [70]Franceschi C Monti D,Sansoni P,et al.The immunology of exceptional individuals:the lesson of centenarians.Immunol Today,1995,16:12-16.
    [71]Putics A,V(?)gh EM,Csermely P,Soti C.Resveratrol induces the heat-shock response and protects human cells from severe heat stress.Antioxid Redox Signal 2008;10:65-75
    [72]Kletsas D,Pratsinis H,Gioni V,Pilichos K,Yiacoumettis AM,Tsagarakis S.Prior chronic in vivo glucocorticoid excess leads to an anabolic phenotype and an extension of cellular life span of skin fibroblasts in vitro.Ann N Y Acad Sci 2007;1100:449-54
    [73]Milner CM,Campbell RD.Structure and expression of the three MHC21inked HSP70 genes[J].Immunogenetics,1990,32:242-251
    [74]Altomare K,Greco V,Bellizzi D,Berardelli M,Dato S,DeRango E et ah The allele (A)(-110) in the promoter region of the HSP70-1 gene is unfavorable to longevity in women.Biogerontology 2003;4:215-20
    [75]Ross OA,Curran MD,Crum KA,Rea IM,Barnett YA,Middleton D.Increased frequency of the 2437T allele of the heat shock protein 70-Hom gene in an aged Irish population.Exp Gerontol 2003;38:561-5
    [76]Singh R,Kolvraa S,Bross P,et al.Heat-shock protein 70 genes and human longevity:a view from Denmark.Ann N Y Acad Sci 2006;1067:301-8
    [77]Ritchie MD,Hahn LW,Roodi N,et al.Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer.Am J Hum Genet 2001;69:138-47.
    [78]Moore JH,Williams SM.New strategies for identifying gene-gene interactions in hypertension.Ann Med 2002;34:88-95
    [79]Moore JH,Gilbert JC,Tsai CT,et al.A flexible computational framework for detecting,characterizing,and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility.J Theor Biol 2006;241:252-61
    [80]Manuguerra M,Matullo G,Veglia F,et al.Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions.Carcinogenesis 2007;28:414-22
    [81]Caruso C,Candore G,Colonna Romano G,Lio D,Bonafe M,Valensin S,Franceschi C.Immunogenetics of longevity complex polymorphism relevant to the control of human longevity? A review of literature data.Mech Ageing and Dev.2001;122:445-462
    [82]Candore G,Lio D,Colonna Romano G,Caruso C.Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype:effect of multiple gene interactions.Autoimmunity Rev.2002;1:29-35.doi:10.1016/S1568-9972(01)00004-0
    [83]Proust J,Moulias R,Fumeron F,Bekkhoucha F,Busson M,Schimd M,Hors J.HLA and longevity.Tissue Antigens.1982;19:168-173
    [84]Lagaay AM,D'Amaro J,Ligthart GJ,Schreuder GM,van Rood JJ,Hijmans W.Longevity and heredity in humans.Association with human leukocyte antigen phenotype.Ann NY Acad Sci.1991;621:78-89
    [85]Ivanova R,Henon N,Lepage V,Charron D,Vicaut E,Schachter F.HLA-DR alleles display sex-dependent effects on survival and discriminate between individual and familial longevity.Hum Mol Genetics.1998;2:187-194.doi:10.1093/hmg/7.2.187.
    [86]Wang XY,Hurme M,Jylha M,Hervonen A.Lack of association between human longevity and polymorphisms of IL-1 cluster,IL-6,IL-10 and TNF-alpha genes in Finnish nonagenarians.Mech Ageing Dev.2001;123:29-38.doi:10.1016/S0047-6374(01)00338-4
    [87]Ross OA,Curran MD,Rea IM,Hyland P,Duggan O,Barnett CR,Annett K,Patterson C,Barnett YA,Middleton D.HLA haplotypes and TNF polymorphism do not associated with longevity in the Irish.Mech Ageing Dev.2003;124:563-567.doi:10.1016/S0047-6374(03)00037-X
    [88]Wilson AG,Symons JA,McDowell TL,McDevitt HO,Duff GW.Effects of a polymorphism in the human tumor necrosis factor-a promoter on transcriptional activation.Proc Natl Acad Sci USA.1997;94:3195-3199.doi:10.1073/pnas.94.7.3195
    [1]Mcdzhitov R,Janeway C Jr:Innate immunity.N Engl J Med 2000,343:338-344
    [2]Janeway C Jr,Medzhitov R:Viral interference with IL-1 and toll signaling.Annu Rev Immunol 2002,20:197-216
    [3]Kneger M:The other side of scavenger receptors:pattern recognition for host defense.Curr Opin Lipidol 1997,8:275-280
    [4]Muzio M,Natoli G,Saccani S,Levrero M,Mantovani A:The human toll signaling pathway:divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6(TRAF6).J Exp Med 1998,187:2097-2101
    [5]Guha M,Mackman N:LPS induction of gene expression in human monocytes.Cell Signal 2001,13:85-94
    [6]Mitchell RN,Cotran RS:Acute and Chronic Inflammation.In Robbins Basic Pathology Saunderrs,Philadelphia,USA;2003
    [7]Lio D,Caruso C:IL-10,Genetic Polymorphism and Its Relevance to Age-related Diseases.Interleukin-10..2004 Eurekah.com
    [8]Bidwell J,Keen L,Gallagher G,Kimberly R,Huizinga T,McDermott MF,Oksenberg J,McNicholl J,Pociot F,Hardt C,D'Alfonso S:Cytokine gene polymorphism in human disease:on-line databases.Genes Immun 1999,1:3-19
    [9]Gabay C,Kushner I:Acute-phase proteins and other systemic responses to inflammation.N Engl J Med 1999,340:448-54
    [10]Pepys MB,Hirschfield GM:C-reactive protein:a critical update.J Clin Invest 2003,111:1805-12
    [11]Candore G,Colonna-Romano G,Lio D,Caruso C:Immunological and Immunogenetic markers of successful and unsuccessful ageing.Advances in Cell Aging and Gerontology 2003,13:29-45
    [12]Pawelec G,Ouyang Q,Colonna-Romano G,Candore G,Lio D,Caruso C:Is human immunosenescence clinically relevant? Looking for ‘immunological risk phenotypes’.Trends Immunol 2002,23:330-2
    [13]Pawelec G,Akbar A,Caruso C,Effros R,Griibeck-Loebenstein B,Wikby A:Is immunosenescence infectious? Contribution of persistent Herpes viruses to immunosenescence and influence on human longevity.Trends Immunol 2004,25: 406-10
    [14]Lloberas J,Celada A:Effect of aging on macrophage function.Exp Geront 2002,37:1325-1331
    [15]Renshaw M,Rockwell J,Engleman C,Gewirtz A,Katz J,Sambhara S:Cutting edge.-impaired Toll-like receptor expression and function in aging.J Immunol 2002,169:4697-4701
    [16]Pawelec G,Solana R,Remarque E,Mariani E:Impact of aging on innate immunity.J Leukoc Biol 1998,64:703-712
    [17]Plackett TP,Boehmer ED,Faunce DE,Kovacs EJ:Aging and innate immune cells.J Lekoc Biol 2004,76:1-9
    [18]Di Lorenzo G,Balistreri CR,Candore G,Cigna D,Colombo A,Romano GC,Colucci AT,Gervasi F,Listi F,Potestio M,Caruso C:Page 11 of 14
    [19]Fagiolo U,Cossarizza A,Scala E,Fanales-Belasio E,Ortolani C,Cozzi E,Monti D,Franceschi C,Paganelli R:Increased cytokine production in mononuclear cells of healthy elderly people.Eur J Immunol 1993,23:2375-2378
    [20]Bruunsgaard H,Pedersen M,Pedersen BK:Aging and proinflammatory cytokines.Curr Opin Hematol 2001,131:131-136
    [21]Ershler WB,Keller ET:Age-associated increased interleukin-6 gene expression,late-life diseases,and frailty.Annu Rev Med 2000,51:245-270
    [22]Baggio G,Donazzan S,Monti D,Mari D,Martini S,Gabelli C,Dalla Vestra M,Previato L,Guido M,Pigozzo S,Cortella I,Crepaldi G,Franceschi C:Lipoprotein(a)and lipoprotein profile in healthy centenarians:a reappraisal of vascular risk factors.FASEB J 1998,12:433-437
    [23]Dumont P,Balbeur L,Remade J,Toussaint O:Appearance of biomarkers of in vitro ageing after successive stimulation of WI-38 fibroblasts with IL-1 alpha and TNF-alpha:senescence associated beta-galactosidase activity and morphotype transition.J Anat 2000,197:529-537
    [24]Vasto S,Caruso C:Immunity & Ageing:a new journal looking at ageing from an immunological point of view.Immun Ageing 2005,2:1
    [25]Pawelec G,Barnett Y,Forsey R,Frasca D,Globerson A,McLeod J,Caruso CFranceschi C,Fulop T,Gupta S,Mariani E,Mocchegiani E,Solana R:T cells and aging.Front Biosci 2002,7:d1056-1183
    [26]Franceschi C,Bonafe M,Valensin S,Olivieri F,De Luca M,Ottaviani E,De Benedictis G:Inflamm-aging.An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000,908:208-218
    [27]Franceschi C,Bonafe M:Centenarians as a model for healthy aginy.Biochem Soc Trans 2003,31:457-461
    [28]Krabbe KS,Pedersen M,Bruunsgaard H:Inflammatory mediators in the elderly.Exp Gerontol 2004,39:687-699
    [29]Rudin E,Barzilai N:Inflammatory peptides derived from adipose tissue.Immun Ageing 2005,2:1
    [30]Finch CE,Crimmins EM:Inflammatory exposure and historical changes in human life-spans.Science 2004,305:1736-1739
    [31]Ridker PM,Morrow DA:C-reactive protein,inflammation,and coronary risk.Cardiol Clin 2003,21:315-325
    [32]Zhu J,Quyyumi AA,Norman JE,Csako G,Waclawiw MA,Shearer GM,Epstein SE:Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels.Am J Cardiol 2000,85:140-146
    [33]Ferrucci L,Harris TB,Guralnik JM,Tracy RP,Corti MC,Cohen HJ,Penninx B,Pahor M,Wallace R,Havlik RJ:Serum IL-6 level and the development of disability in older persons.J Am Geriatr Soc 1999,47:639-646
    [34]Harris TB,Ferrucci L,Tracy RP,Corti MC,Wacholder S,Ettinger WH Jr,Heimovitz H,Cohen HJ,Wallace R:Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly.Am J Med 1999,106:506-512
    [35]Volpato S,Guralnik JM,Ferrucci L,Balfour J,Chaves P,Fried LP,Harris TB:Cardiovascular disease,interleukin-6,and risk of mortality in older women:the women's health and aging study.Circulation 2001,103:947-953.
    [36]Bruunsgaard H,Andersen-Ranberg K,Hjelmborg JB,Pedersen BK,Jeune B:Elevated levels of tumor necrosis factor alpha and mortality in centenarians.Am J Med 2003,115:278-283
    [37]Bruunsgaard H,Ladelund S,Pedersen AN,Schroll M,J.rgensen T,Pedersen BK:Predicting death from tumor necrosis factor-alpha and interleukin-6 in 80-year-old people.Clin Exp Immunol 2003,132:24-31
    [38]Reuben DB,Cheh AI,Harris TB,Ferrucci L,Rowe JW,Tracy RP,See-man TE:Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons.J Am Geriatr Soc 2002,50:638-644
    [39]Mysliwska J,Bryl E,Foerster J,Mysliwski:A.Increase of interleukin 6 and decrease of interleukin 2 production during the ageing process are influenced by the health status.Mech Ageing Dev 1998,100:313-328
    [40]Fried LP,Tangen CM,Walston J,Newman AB,Hirsch C,Gottdiener J,Seeman T,Tracy R,Kop WJ,Burke G,McBurnie MA:Frailty in older adults:evidence for a phenotype.J Gerontol A Biol Sci Med Sci 2001,56:M146-M156
    [41]Hamerman D:Toward an understanding of frailty.Ann Intern Med 1999,130:945-950
    [42]Roubenoff R,Hughes V:Sarcopenia-.current concepts.J Gerontol A Biol Sci Med Sci 2000,55:M716-M724
    [43]Brown W:A method for estimating the number of motor units in thenar muscles and the changes in motor unit count with aging.J Neurosurg Psych 1972,35:845-852
    [44]Roubenoff R:Catabolism of aging:is it an inflammatory process? Curr Opin Clin Nutr Metab Care 2003,6:295-299
    [45]Pedersen M,Bruunsgaard H,Weis N,Hendel HW,Andreassen BU,Eldrup E,Dela F,Pedersen BK:Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes.Mech Ageing Dev 2003,124:495-502
    [46]Visser M,Pahor M,Taaffe DR,Goodpaster BH,Simonsick EM,Newman AB,Nevitt M,Harris TB:Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women:the Health ABC study.J Gerontol A Biol Sci Med Sci 2002,57:M326-M332
    [47]Ferrucci L,Penninx BW,Volpato S,Harris TB,Bandeen-Roche K,Balfour J,Leveille SG,Fried LP,Md JM:Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels.J Am Geriatr Soc 2002,50:1947-1954
    [48]Greiwe JS,Cheng B,Rubin DC,Yarasheski KE,Semenkovich CF:Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans.FASEB J 2001,15:475-482
    [49]Bruunsgaard H,Bjerregaard E,Schroll M,Pedersen BK:Muscle strength following resistance training is inversely correlated with baseline levels of soluble tumor necrosis Factor receptors in the oldest old.J Am Geriatr Soc 2004,52:237-241
    [50]Barbieri M,Ferrucci L,Ragno E,Corsi A,Bandinelli S,Bonafe M,Olivieri F,Giovagnetti S,Franceschi C,Guralnik JM,Paolisso G:Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons.Am J Physiol Endocrinol Metab 2003,284:E481-487
    [51]Cappola AR,Xue QL,Ferrucci L,Guralnik JM,Volpato S,Fried LP:Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women.J Clin Endocrinol Metab 2003,88:2019-2025
    [52]Kern PA,Ranganathan S,Li C,Wood L,Ranganathan G:Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance.Am J Physiol Endocrinol Metab 2001,280:E745-E751
    [53]Senn J,Klover P,Nowak I,Mooney R:Interleukin-6 induces cellular insulin resistance in hepatocytes.Diabetes 2002,51:3391-3399
    [54]Hotamisligil GS,Shargill NS,Spiegelman BM:Adipose expression of tumor necrosis factor-alpha:direct role in obesity linked insulin resistance.Science 1993,259:87-91
    [55]Kereiakes DJ,Willerson JT:Metabolic syndrome epidemic.Circulation 2003,108:1552-1553.56.Calle EE,Thun MJ,Petrelli JM,Rodriguez C,Heath CW Jr:Body-mass index and mortality in a prospective cohort of U.S.adults.N Engl J Med 1999,341:1097-105
    [56]Yudkin JS,Stehouwer CD,Emeis JJ,Coppack SW:C-reactive protein in healthy subjects:associations with obesity,insulin resistance,and endothelial dysfunction:a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vase Biol 1999,19:972-978
    [57]Neel JV:Diabetes mellitus:a “thrifty” genotype rendered detrimental by “progress”?Am J Hum Genet 1962,14:353-362
    [58]Diamond J:The double puzzle of diabetes.Nature 2003,423:599-602
    [59]Lazar MA:How obesity causes diabetes:not a tall tale.Science 2005,307:373-375
    [60]Tracy RO:Inflammation,the metabolic syndrome and cardiovascular risk.Int Clin Pract Suppl 2003,134:10-17
    [61]Das U:Metabolic syndrome X:an inflammatory condition? Curr Hypertens Rep 2004,6:66-73
    [62]Kern PA,Saghizadeh M,Ong JM,Bosch RJ,Deem R,Simsolo RB:The expression of tumor necrosis factor in human adipose tissue.Regulation by obesity,weight loss,and relationship to lipoprotein lipase.J Clin Invest 1995,95:2111-2119
    [63]Yudkin JS,Stehouwer CD,Emeis JJ,Coppack SW:C-reactive protein in healthy subjects:associations with obesity,insulin rcsistance,and endothelial dysfunction:a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999,19:972-978
    [64]Mohamed-Ali V,Goodrick S,Rawesh A,Katz DR,Miles JM,Yudkin JS,Klein S,Coppack SW:Subcutaneous adipose tissue releases interleukin-6,but not tumor necrosis factor-α,in vivo.J Clin Endocrinol Metab 1997,82:4196-4200
    [65]Lundgren CH,Brown SL,Nordt TK,Sobcl BE,Fujii S:Elaboration of type-1 plasminogen activator inhibitor from adipocytes.A potential pathogenetic link between obesity and cardiovascular disease.Circulation 1996,93:106-110
    [66]Curat CA,Miranville A,Sengenes C,Diehl M,Tonus C,Busse R,Bouloumie A:From blood monocytes to adipose tissue-resident macrophages:induction of diapedesis by human mature adipocytes.Diabetes 2004,53:1285-1292
    [67]Perseghin G,Petersen K,Shulman GI:Cellular mechanism of insulin resistance:potential links with inflammation.Int J Obes Relat Metab Disord 2003,3:s6-11.
    [68]Haffner SM:Insulin resistance,inflammation,and the prediabetic state.Am J Cardiol 2003,92:18J-26J
    [69]Dandona P,Aljada A,Bandyopadhyay A:Inflammation:the link between insulin resistance,obesity and diabetes.Trends Immunol 2004,25:4-7
    [70]Spranger J,Kroke A,Mohlig M,Hoffmann K,Bergmann MM,Ristow M,Boeing H,Pfeiffer AF:Inflammatory cytokines and the risk to develop type 2 diabetes:results of the prospective population-based European Prospective Investigation into Cancer and Nutrition(EPIC)-Potsdam Study.Diabetes 2003,52:812-817
    [71]Festa A,Hanley AJ,Tracy RP,D'Agostino R Jr,Haffner SM:Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.Circulation 2003,108:1822-1830
    [72]Temelkova-Kurktschiev T,Siegert G,Bergmann S,Henkel E,Koehler C,Jaross W,Hanefeld M:Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes.Metabolism 2002,51:743-749
    [73]Abbatecola AM,Ferrucci L,Grella R,Bandinelli S,Bonafe M,Barbieri M,Corsi AM,Lauretani F,Franceschi CPaolisso G:Diverse effect of inflammatory markers on insulin resistance and insulin-resistance syndrome in the elderly.J Am Geriatr Soc 2004,52:399-404
    [74]Hotamisligil GS,Budavari A,Murray D,Spiegelman BM:Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes.Central role of tumor necrosis factor-a J Clin Invest 1994,94:1543-1549
    [75]Kubaszek A,Pihlajamaki J,Komarovski V,Lindi V,Lindstrom J,Eriksson J,Valle TT,Hamalainen H,Ilanne-Parikka P,Keinanen-Kiukaanniemi S,Tuomilehto J,Uusitupa M,Laakso M:Finnish Diabetes Prevention Study.Promoter polymorphisms of the TNF-alpha(G-308A)and IL-6(C-174G)genes predict the conversion from impaired glucose tolerance to type 2 diabetes:the Finnish Diabetes Prevention Study.Diabetes 2003,52:1872-1876
    [76]Aljada A,Ghanim H,Mohanty P,Kapur N,Dandona P:Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1(Egr)-1 expression in mononuclear cells(MNC)and reduces plasma tissue factor(TF)and plasminogen activator inhibitor-1(PAI-1)concentrations.J Clin Endocrinol Metab 2002,87:1419-1422
    [77]Das M,Gabriely I,Barzilai N:Caloric restriction,body fat and ageing in experimental models.Obes Rev 2004,5:13-19
    [78]DePinhoRA:The age of cancer.Nature 2000,408:248-254
    [79]Caruso C,Lio D,Cavallone L,Franceschi C:Aging,Longevity,Inflammation,and Cancer.Ann NY Acad Sci 2004,1028:1-13
    [80]Repetto L,Venturino A,Fratino L,Serraino D,Troisi G,Gianni W,Pietropaolo M:Geriatric oncology:a clinical approach to the older patient with cancer.Eur J Cancer 2003,39:870-880
    [81]Thun MJ,Henley SJ,Gansler T:Inflammation and cancer:an epidemiological perspective.Novartis Found Synp 2004,256:2-21
    [82]Macarthur M,Hold GL,El-Omar EM:Inflammation and Cancer Ⅱ.Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy.Am J Physiol Gastointest Liver Physiol 2004,286:G515-20
    [83]Brigati C,Noonan DM,Albini A,Benelli R:Tumors and inflammatory infiltrates:friends or foes? Clin Exp Metastasis 2002,19:247-258
    [84]Balkwill F,Mantovani A:Inflammation and cancer:back to Virchow.Lancet 2001,357:539-545
    [85]Erlinger TP,Platz EA,Rifai N,Helzlsouer KJ:C-reactive protein and the risk of incident colorectal cancer.JAMA 2004,291:585-90
    [86]McMillan DC,Canna K,McArdle CS:Systemic inflammatory response predicts survival following curative resection of colorectal cancer.Br J Surg 2003,90:215-219
    [87]Bonafe M,O1ivieri F,Cavallone L,Giovagnetti S,Mayegiani F,Cardelli M,Pieri C,Marra M,Antonicelli R,Lisa R,Rizzo MR,Paolisso G,Monti D,Franceschi C:A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity.Eur J Immunol 2001,31:2357-2361
    [88]Lio D,Scola L,Crivello A,Colonna-Romano G,Candore G,Bonafe M,Cavallone L,Franceschi C,Caruso C:Gender-specific association between-1082 IL-10 promoter polymorphism and longevity.Genes Immun 2002,3:30-33.
    [89]Lio D,Scola L,Crivello A,Colonna-Romano G,Candore G,Bonafe M,Cavallone L,Marchegiani F,Olivieri F,Franceschi C,Caruso C:Inflammation,genetics,and longevity:further studies on the protective effects in men of IL-10-1082 promoter SNP and its interaction with TNF-alpha-308 promoter SNP.J Med Genet 2003,40:296-299
    [90]Caruso C,Candore QColonna Romano G,Lio D,Bonafe M,Valensin S,Franceschi C:HLA,aging,and longevity:a critical reappraisal.Hum Immunol 2000,61:942-249
    [91]Shin HD,Park BL,Kim LH,Jung JH,Kim JY,Yoon JH,Kim YJ,Lee HS:Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma.Hum Mol Genet 2003,12:901-906
    [92]Hussain SP,Hofseth LJ,Harris CC:Radical causes of cancer.Nature Rev Cancer 2003,3:276-285
    [93]Szlosarek PW,Balkwill FR:Tumor necrosis factor alpha:a potential target for the therapy of solid tumors.Lancet Oncol 2003,4:565-573
    [94]Braunwald E:Shattuck lecture-cardiovascular medicine at the turn of the millennium:triumphs,concerns,and opportunities.N Engl J Med 1997,337:1360-1369
    [95]Libby P,Ridker PM,Maseri A:Inflammation and atherosclerosis.Circulation 2002,105:1135-1143
    [96]Ross R:Atherosclerosis:An inflammatory disease.N Engl J Med 1999,340:115-126
    [97]LusisAJ:Atherosclerosis.Nature 2000,407:233-241
    [98]Libby P:Inflammation in atherosclerosis.Nature 2002,420:868-874
    [99]Rifai N,Ridker PM:Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening.Clin Chem 2001,47:28-30
    [100]Ridker PM,Rifai N,Stampfer MJ,Hennekens CH:Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.Circulation 2000,101:1767-1772
    [101]Hansson GK,Libby P,Schonbeck U,Yan ZQ:Innate and aquired immunity in the pathogenesis of atherosclerosis.Circulation Res 2002,91:281-291
    [102]Ridker PM,Hennekens CH,Buring JE,Rifai N:C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.N Engl J Med 2000,342:836-843
    [103]Ridker PM,Rifai N,Rose L,Buring JE,Cook NR:Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.N Engl J Med 2002,347:1557-1565
    [104]Di Iorio A,Ferrucci L,Sparvieri E,Cherubim A,Volpato S,Corsi A,Bonafe M,Franceschi C,Abate G,Paganelli R:Serum IL-lbeta levels in health and disease:a population-based study.The InCHLANTI study'.Cytokine 2003,22:198-205
    [105]Barbieri M,Ferrucci L,Corsi AM,Macchi C,Lauretani F,Bonafe M,Olivieri F,Giovagnetti S,Franceschi C,Paolisso G:Is chronic inflammation a determinant of blood pressure in the elderly? Am J Hypertens 2003,16:537-543
    [106]Nabel EG:Cardiovascular disease.N Engl J Med 2003,349:60-72
    [107]Andreotti F,Porto I,Crea F,Maseri A:Inflammatory gene polymorphisms and ischaemic heart disease:review of population association studies.Heart 2002,87:107-112
    [108]Stephens JW,Humphries SE:The molecular genetics of cardiovascular disease:clinical implications.J Intern Med 2003,253:120-127
    [109]Lio D,Candore G,Crivello A,Scola L,Colonna-Romano L,Cavallone L,Hoffmann E,Caruso M,Licastro F,Caldarera CM,Branzi A,Franceschi C,Caruso C:Opposite effects of IL-10 gene polymorphisms in cardiovascular diseases and in successful ageing:genetic background of male centenarians is prospettive against coronary heart disease.J Med Genet 2004,41:790-794
    [110]Listi F,Candore G,Lio D,Cavallone L,Colonna-Romano G,Caruso M,Hoffmann E,Caruso C:Association between platelet endothelial cellular adhesion molecule 1(PECAM-1/CD31)polymorphisms and acute myocardial infarction:a study in patients from Sicily.Eur J Immunogenet 2004,31:175-178
    [111]Licastro F,Chiappelli M,Caldarera CM,Tampieri C,Nanni S,Gallina M,Branzi A: The concomitant presence of polymorphic alleles of interleukin-lbeta,interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men.Results from a pilot study.Mech Ageing Dev 2004,125:575-579
    [112]Benagiano M,Azzurri A,Ciervo A,Amedei A,Tamburini C,Ferrari M,Telford JL,Baldari CT,Romagnani S,Cassone A,D'Elios MM,Del Prete G:T helper type 1lymphocytes drive inflammation in human atherosclerotic lesions.Proc Natl Acad Sci U S A.Epub 2003,100:6658-6663
    [113]Gupta S,Pablo AM,Jiang X,Wang N,Tall AR,Schindler C:IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.J Clin Invest 1997,99:2752-2761
    [114]Whitman SC,Ravisankar P,Elam H,Daugherty A:Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E/-mice.Am J Pathol 2000,157:1819-1824
    [115]Hansson GK:The B cell:a good guy in vascular disease? Arterioscler Thromb Vasc Biol 2002,22:523-524
    [116]Wick G,Knoflach M,Xu Q:Autoimmune and inflammatory mechanisms in atherosclerosis.Annu Rev Immunol 2004,22:361-403
    [117]Brookmeyer R,Gray S,Kawas C:Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.Am J Public Health 1998,88:1337-1342
    [118]Selkoe DJ:Alzheimer's disease:genes,proteins,and therapy.Physiol Rev 2001,81:741-766
    [119]Ritchie K,Lovestone S:The dementias.Lancet 2002,360:1759-1766.
    [120]McGeer EG,McGeer PL:The importance of inflammatory mechanisms in Alzheimer disease.Exp Geront 1998,33:371-378
    [121]Licastro F:Genomics of immune molecules:early detection of cognitive decline and new therapeutic interventions.Expert Rev Neurotherapeutics 2002,2:639-645
    [122]Lee YB,Nagai A,Kim SU:Cytokines,chemokines,and cytokine receptors in human microglia.J Neurosci Res 2002,69:94-103
    [123]In t' Veld BA,Ruitenberg A,Hofman A:Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease.N Engl J Med 2001,345:1515-1521
    [124]Vagnucci AH Jr,Li WW:Alzheimer's disease and angiogenesis.Lancet 2003,361:605-608
    [125]Schmidt R,Schmidt H,Curb JD,Masaki K,White LR,Launer LJ:Early inflammation and dementia:a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 2002,52:168-174
    [126]Licastro F,Pednni S,Caputo L,Annoni G,Davis LJ,Ferri C,Casadci V.Grimaldi LM:Increased plasma levels of interleukin-l,interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease:peripheral inflammation or signals from the brain? J Neuroimmunol 2000,103:97-102
    [127]Licastro F,Pedrini S,Ferri C,Casadei V,Govoni M,Pession A,Sciacca FL,Veglia F,Annoni G,Bonafe M,Olivieri F,Franceschi C,Grimaldi LM:Gene polymorphism affecting alpha 1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk.Ann Neurol 2000,48:388-391
    [128]De Luigi A,Fragiacomo C,Lucca U,Quadri P,Tettamanti M,Grazia De Simoni M:Inflammatory markers in Alzheimer's disease and multi-infarct dementia.Mech Ageing Dev 2001,122:1985-1995
    [129]Licastro F,Chiappelli M:Brain immune responses cognitive decline and dementia:relationship with phenotype expression and genetic background.Mech Ageing Dev 2003,124:525-528
    [130]Licastro F,Grimaldi LM,Bonafe M,Martina C,Olivieri F,Cavallone L,Giovanietti S,Masliah E,Franceschi C:Interleukin-6 gene allelesaffect the risk of Alzheimer's disease and levels of the cytokine in blood and brain.Neurobiol Aging 2003,24:921-926
    [131]Candore G,Balistreri CR,Colonna-Romano G,Lio D,Caruso C:Major histocompatibility complex and sporadic Alzheimer's disease:a critical reappraisal.Exp Gerontol 2004,39:645-52
    [132]Akiyama H,Barger S,Barnum S,Bradt B,Bauer J,Cole GM,Cooper NR,Eikelenboom P,Emmerling M,Fiebich BL,Finch CE,Frautschy S,Griffin WS,Hampel H,Hull M,Landreth G,Lue L,Mrak R,Mackenzie IR,McGeer PL,O'Banion MK,Pachter J,Pasinetti G,Plata-Salaman C,Rogers J,Rydel R,Shen Y,Streit W,Strohmeyer R,Tooyoma I,Van Muiswinkel FL,Veerhuis R,Walker D,Webster S,Wegrzyniak B,Wenk G,Wyss-Coray T:Inflammation and Alzheimer's disease.Neurobiol Aging 2000,21:383-421
    [133]Scola L,Licastro F,Chiappelli M,Franceschi C,Grimaldi LM,Crivello A,Colonna-Romano G,Candore G,Lio D,Caruso C:Allele frequencies of +874T->A single nucleotide polymorphism at the first intron of IFN-gamma gene in Alzheimer's disease patients.Aging Clin Exp Res 2003,15:292-295
    [134]Lio D,Licastro F,Scola L,Chiappelli M,Grimaldi LM,Crivello A,Colonna-Romano G,Candore G,Franceschi C,Caruso C:Interleukin10 promoter polymorphism in sporadic Alzheimer's disease.Genes Immun 2003,4:234-238
    [135]McGeer PL,McGeer EG:Polymorphisms in inflammatory genes and the risk of Alzheimer disease.Arch Neurol 2001,58:1790-1792
    [136]Nesse RM,Williams GC:Evolution and Healing.The New Science of Darwinian Medicine.Weidenfeld & Nicolson,UK;1995
    [137]Brod SA:Unregulated inflammation shortens human functional longevity.Inflamm Res 2000,49:561-570
    [138]Franceschi C,Olivieri F,Marchegiani F,Cardelli M,Cavallone L,Capri M,Salvioli S,Valensin S,De Benedictis G,Di Iorio A,Caruso C,Paolisso G,Monti D:Genes involved in immune response/ inflammation,IGFl/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity:the lesson of centenarians.Mech Ageing Dev 2005,126:351-361
    [139]Caruso C,Candore G,Colonna-Romano G,Lio D,Franceschi C:Inflammation and life-span.Science 2005,307:208-209
    [140]Wick G,Berger P,Jansen-Durr P,Grubeck-Loebenstein B:A Darwinian-evolutionary concept of age-related diseases.Exp Gerontol 2003,38:13-25
    [141]Mariani L,Turchetti G,Franceschi C:Chronic antigenic stress,immunosenescence and human survivorship over the 3 last centuries:heuristic value of a mathematical model.Mech Ageing Dev 2003,124:453-458.
    [142]Balistreri CR,Candore G,Colonna-Romano G,Lio D,Caruso M,Hoffmann E,Franceschi C,Caruso C:Role of Toll-like receptor 4 in acute myocardial infarction and longevity.JAMA 2004,292:2339-2340
    [1]Hasty,P.,Campisi,J.,Hoeijmakers,J.,van Steeg,H.,Vijg,J.,2003.Aging and genome maintenance:lessons from the mouse? Science 299,1355-1359
    [21 Barker,D.J.,2004.The developmental origins of chronic adult disease.Acta Paediatr.(Suppl.93),26-33
    [3]Reyes,L.,Manalich,R.,2005.Long-term consequences of low birth weight.Kidney Int.(Suppl.97),S107-S111
    [4]de Magalhaes,J.P.,2005.Open-minded scepticism:inferring the causal mechanisms of human ageing from genetic perturbations.Ageing Res.Rev.4,1-22.
    [5]De Benedictis,G,Franceschi,C,2006.The unusual genetics of human longevity.Sci.Aging Knowledge Environ.10,pe20.
    [6]Hawkes,K.,2003.Grandmothers and the evolution of human longevity.Am.J.Human Biol.15,380-400.
    [7]Hjelmborg,J.V.,Iachine,I.,Skytthe,A.,Vaupel,J.W.,McGue,M,Koskenvuo,M.,Clayton,D.A.,Teplitz,R.L.,Nabholz,M.,Dovey,H.,Bodmer,W.,1971.Mitochondrial DNA of human-mouse cell hybrids.Nature 234,560-562.
    [8]Ballard,J.W.,James,A.C.,2004.Differential fitness of mitochondrial DNA in perturbation cage studies correlates with global abundance and population history in Drosophila simulans.Proc.Biol.Sci.271,1197-1201
    [9]Roubertoux,P.L.,Sluyter,F.,Carlier,M.,Marcet,B.,Maarouf-Veray,F.,Cherif,C,Marican,C.,Arrechi,P,Godin,F.Jamon,M.,Verrier,B.,Cohen-Salmon,C,2003.Mitochondrial DNA modifies cognition in interaction with the nuclear genome and age in mice.Nat.Genet.35,65-69
    [10]Zhang,J.,Asin-Cayuela,J.,Fish,J.,Michikawa,Y.,Bonafe,M.,Olivieri,F.,Passarino,G,De Benedictis,G,Franceschi,C,Attardi,G,2003.Strikingly higher frequency in centenarians and twins of mtDNA mutation causing remodeling of replication origin in leukocytes.Proc.Natl.Acad.Sci.U.S.A.100,1116-1121
    [11]Niemi,A.K.,Moilanen,J.S.,Tanaka,M.,Hervonen,A.,Hurme,M.,Lehtimaki,T.,Arai,Y.,Hirose,N.,Majamaa,K.,2005.A combination of three common inherited mitochondrial DNA polymorphisms promotes longevity in Finnish and Japanese subjects.Eur.J.Hum.Genet.13,166-170
    [12]Santoro,A.,Salvioli,S.,Raule,N.,Capri,M.,Sevini,F,Valensin,S.,Monti,D., Bellizzi,D.,Passarono,G.,Rose,G.,De Bencdictis,G.,Franceschi,C.,2006.Mitochondrial DNA involvement in human longevity.Biochim.Biophys.Acta 1757,1388-1399
    [13]Carried,G.,Bonafe,M.,De Luca,M.,Rose,G.,Varcasia,O.,Bruni,A.,Maletta,R.,Nacmias,B.,Sorbi,S.,Corsonello,F.,Feraco.E.,Andreev,K.R,Yashin,A.I.,Franceschi,C.,De Bencdictis,G.,2001.Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease.Hum.Genet.108,194-198
    [14]Ruiz-Pesini,E.,Mishmar,D.,Brandon,M.,Procaccio,V.,Wallace,D.C.,2004.Effects of purifying and adaptive selection on regional variation in human mtDNA.Science 303,223-226
    [15]Kivisild,T.,Shen,P.,Wall D.P.,Do,B.,Sung,R.,Davis,K.,Passarino,G.,Underhill,P.A.,Scharfe,C.,Torroni,A.,Scozzari,R.,Modiano,D.,Coppa,A.,de Knijff,P.,Feldman,M.,Cavalli-Sforza,L.L.,Oefner,P.J.,2006.The role of selection in the evolution of human mitochondrial genomes.Genetics 172,373-387.
    [16]Bellizzi,D.,Cavalcante,P.,Taverna,D.,Rose,G.,Passarino,G.,Salvioli,S.,Franceschi,C.,De Benedictis,G.,2006.Gene expression of cytokines and cytokine receptors is modulated by the common variability of the mitochondrial DNA in cybrid cell lines.Genes Cells 11,883-891
    [17]Poulain,M.,Pes,G.M.,Grasland,C.,Carru,C.,Ferrucci,L.,Baggio,G.,Franceschi,C.,Deiana,L.,2004.Identification of a geographic area characterized by extreme longevity in the Sardinia island:the AKEA study.Exp.Gerontol.39,1423-1429
    [18]Caselli,G.,Pozzi,L.,Vaupel,J.W.,Deiana,L.,Pes,G.,Carru,C.,Franceschi,C.,Baggio,G.,2006.Family clustering in Sardinian longevity:a genealogical approach.Exp.Gerontol.41,727-736
    [19]De Benedictis,G.,Rose,G.,Carrieri,G.,De Luca,M.,Falcone,E.,Passarino,G.,Bonafe,M.,Monti,D.,Baggio,G.,Bertolini,S.,Mari,D.,Mattace,R.,Franceschi,C.,1999.Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans.FASEB J.13,1532-1536
    [20]Schachter,R,Faure-Delanef,L.,Guenot,R,Rouger,H.,Froguel,P.,Lesueur-Ginot,L.,Cohen,D.,1994.Genetic associations with human longevity at the APOE and ACE loci.Nat.Genet.6,29-32.
    [21]Christiansen,L.,Brasch-Andersen,C.,Bathum,L.,Kruse,T.A.,Christensen,K.,2006.A longitudinal study of the effect of GSTT1 and GSTM1 gene copy number on survival.Vlech.Ageing Dev.127,597-599
    [22]Bonafe,M..Olivieri,F.,Cavallone,L.,Giovagnetti,S.,Marchegiani,R,Cardelli,M.,Pieri,C Marra,M.,Antonicelli,R.,Lisa,R.,Rizzo,M.R.,Paolisso,G.,Monti,D.,Franceschi,C.,2001.A gender-dependent genetic predisposition to produce high levels of IL-(?)is detrimental for longevity.Eur.J.Immunol.31,2357-2361
    [23]Rea,I.M.,McKeown,P.P.,McMaster,D.,Young,I.S.,Patterson,C.,Savage,M.J.,Belton,C.,Marchegiani,R,Olivieri,R,Bonafe,M.,Franceschi,C.,2004.Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians.A pooled analysis.Exp.Gerontol.39,629-635
    [24]Franceschi,C.,Olivieri,R,Marchegiani,R,Cardelli,M.,Cavallone,L.,Capri,M.,Salvioli,S.,Valensin,S.,De Benedictis,G.,Di Iorio,A.,Caruso,C.,Paolisso,G.,Monti,D.,2005.Genes involved in immune response/inflammation,IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity:the lesson of centenarians.Mech.Ageing Dev.126,351-361
    [25]O'Hara,A.M.,Shanahan,R,2006.The gut flora as a forgotten organ.EMBO Rep.7,688-693.
    [26]Ottaviani,E.,Franceschi,C.,1997.The invertebrate phagocytic immunocyte:clues to a common evolution of immune and neuroendocrine systems.Immunol.Today 18,169-174
    [27]Pancer,Z.,Cooper,M.D.,2006.The evolution of adaptive immunity.Annu.Rev.Immunol.24,497-518
    [28]Guarner,F.,2006.Enteric flora in health and disease.Digestion 73(Suppl.1),5-12.
    [29]Ottaviani,E.,Franceschi,C.,1998.A new theory on the common evolutionary origin of natural immunity,inflammation and stress response:the invertebrate phagocytic immunocyte as an eye-witness.Domest.Anim.Endocrinol.15,291-296
    [30]Franceschi,C.,Bonafe,M.,Valensin,S.,Olivieri,R,De Luca,M.,Ottaviani,E.,De Benedictis,G.,2000b.Inflamm-aging.An evolutionary perspective on immunosenescence.Ann.N.Y.Acad.Sci.908,244-254
    [31]Bruunsgaard,H.,Andersen-Ranberg,K.,Jeune,B.,Pedersen,A.N.,Skinhoj,P.,Pedersen,B.K.,1999.A high plasma concentration of TNF-alpha is associated with dementia in centenarians.J.Gerontol.A:Biol.Sci.Med.Sci.54,M357-M364
    [32]Ouyang,Q.,Wagner,W.M.,Voehringer,D.,Wikby,A.,Klatt,T.,Walter,S.,Muller,C.A.,Pircher,H.,Pawelec,G.,2003.Age-associated accumulation of CMV-specific CD8 + T cells expressing the inhibitory killer cell lectin-like receptor G1(KLRG1). Exp.Gerontol.38.911-920
    [33]Vescovini,R.,Telera,A.,Fagnoni,F.F.,Biasimi,C.,Medici,M.C Valcavi,P.,di Pede,P.,Lucchini,G.,Zanlari,L,Passed,G.,Zanni,F.,Chezzi,C.,Franceschi,C.,Sansoni,P.,2004.Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells.Exp.Gerontol.39,1233-1243
    [34]Pawelec,G.,Koch,S.,Franceschi,C.,Wikby,A.,2006.Human immunosenescence:does it have an infectious component? Ann.N.Y.Acad.Sci.1067,56-65
    [35]Koch,S.,Solana,R.,De la Rosa,O.,Pawelec,G.,2006.Human cytomegalovirus infection and T cell immunosenescence:a mini review.Mech.Ageing Dev.127,538-543
    [36]Wikby,A.,Nilsson,B.O.,Forsey,R.,Thompson,J.,Strindhall,J.,Lofgren,S.,Ernerudh,J.,Pawelec,G.,Ferguson,F.,Johansson,B.,2006.The immune risk phenotype is associated with IL-6 in the terminal decline stage:findings from the Swedish NONA immune longitudinal study of very late life functioning.Mech.Ageing Dev.127,695-704
    [37]Schmaltz,H.N.,Fried,L.P.,Xue,Q.L.,Walston,J.,Leng,S.X.,Semba,R.D.,2005.Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women.J.Am.Geriatr.Soc.53,747-754
    [38]Bonfigli,A.R.,Scrolla,C.,Cenerelli,S.,Marra,M.,Boemi,M.,Franceschi,C.,Testa,I.,Mari,D.,Sacchi,E.,Testa,R.,2004.Plasminogen activator inhibitor-1 plasma level increases with age in subjects with the 4G allele at position(?)675 in the promoter region.Thromb.Haemost.92,1164-1165
    [39]Cipriano,C.,Caruso,C.,Lio,D.,Giacconi,R.,Malavolta,M.,Muti,E.,Gasparini,N.,Franceschi,C.,Mocchegiani,E.,2005.The i 308G/A polymorphism of TNF-alpha influences immunological parameters in old subjects affected by infectious diseases.Int.J.Immunogenet.32,13-18
    [40]Baggio,G.,Donazzan,S.,Monti,D.,Mari,D.,Martini,S.,Gabelli,C.,Dalla Vestra,M.,Previato,L.,Guido,M.,Pigozzo,S.,Cortella,I.,Crepaldi,G.,Franceschi,C.,1998.Lipoprotein(a)and lipoprotein profile in healthy centenarians:a reappraisal of vascular risk factors.FASEB J.12,433-436
    [41]Passeri,G.,Pini,G.,Troiano,L.,Vescovili,R.,Sansoni,P.,Passed,M.,Gueresi,P.,Del signore,R.,Pedrazzoni,M.,Franceschi,C.,2003.Low vitamin D status,high bone turnover,and bone fractures in centenarians.J.Clin.Endocrinol.Metab.88, 5109 5115
    [42]Ershlcr,W.B.,Keller,E.T.,2000.Age-associated increased interleukin-6 gene expression,late-life diseases,and frailty.Annu.Rev.Med.51,245-270
    [43]Barbieri,M.,Ferrucci,L.,Ragno,E.,Corsi,A.,Bandinelli,S.,Bonafe,M.,Olivieri,F.,Giovagnetti,S.,Francesclii,C.,Guralnik,J.M.,Paolisso,G.,2003a.Chronic inflammation and the effect of IGF-1 on muscle strength and power in older persons.Am.J.Physiol.Endocrinol.Metab.284,E481-E487
    [44]Mari,D.,Mannucci,P.M.,Coppola,R.,Bottasso,B.,Bauer,K.A.,Rosenberg,R.D.,1995.Hypercoagulability in centenarians:the paradox of successful aging.Blood 85,3144-3149
    [45]Coppola,R.,Mari,D.,Lattuada,A.,Franceschi,C.,2003.Von Willebrand factor in Italian centenarians.Haematologica 88,39-43
    [46]Terry,D.F.,Wyszynski,D.F.,Nolan,V.G.,Atzmon,G.,Schoenhofen,E.A.,Pennington,J.Y.,Andersen,S.L.,Wilcox,M.A.,Fairer,L.A.,Barzilai,N.,Baldwin,C.T.,Asea,A.Serum heat shock protein 70 level as a biomarker of exceptional longevity.Mech.Ageing Dev.,76,1329-1340
    [47]Troiano,L.,Pini,G.,Petruzzi,E.,Ognibene,A.,Franceschi,C.,Monti,D.,Casotti,G.,Cilotti,A.,Forti,G.,1999.Evaluation of adrenal function in aging.J.Endocrinol.Invest.22,74-75
    [48]Schachter,F.,Faure-Delanef,L.,Guenot,F.,Rouger,H.,Froguel,P.,Lesueur-Ginot,L.,Cohen,D.,1994.Genetic associations with human longevity at the APOE and ACE loci.Nat.Genet.6,29-32
    [49]Barbieri,M.,Rizzo,M.R.,Papa,M.,Acampora,R.,De Angelis,L.,Olivieri,F.,Marchigiani,F.,Franceschi,C.,Prolisso,G.,2005.Role of interaction between variants in the PPARG and interleukin-6 genes on obesity related metabolic risk factors.Exp.Gerontol.40,599-604
    [50]Grimaldi,M.P.,Candore,G.,Vasto,S.,Caruso,M.,Caimi,G.,Hoffmann,E.,Colonna-Romano,G.,Lio,D.,Shinar,Y.,Franceschi,C.,Caruso,C.,2006.Role of the pyrin M694V(A2080G)allele in acute myocardial infarction and longevity:a study in the Sicilian population.J.Leukoc.Biol.79,611-615
    [51]Balistreri,C.R.,Candore,G.,Lio,D.,Colonna-Romano,G.,Di Lorenzo,G.,Mansueto,P.,Rini,G.,Mansueto,S.,Cillari,E.,Franceschi,C.,Caruso,C.,2005.Role of TLR4 receptor polymorphisms in Boutonneuse fever.Int.J.Immunopathol.Pharmacol.18,655-660
    [52]Lio,D.,Scola,L.,Crivello,A.,Colonna-Romano,G.,Candore,G.,Bonafe,M.,Cavallone,L.,Franceschi,C.,Caruso,C.,2002.Gender-specific association between-1082 IL-10 promoter polymorphism and longevity.Genes Immun.3,30-33
    [53]Lio,D.,Licastro,F.,Scola,L.,Chiappelli,M.,Grimaldi,L.M.,Crivello,A.,Colonna-Romano,G.,Candore,G.,Franceschi,C.,Caruso,('.,2003.Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease.Genes Immun.4,234-238
    [54]Bonafe,M.,Marchigiani,F.,Cardelli,M.,Olivieri,F.,Cavallone,L.,Giovanetti,S.,Pieri,C.,Marra,M.,Antonicelli,R.,Troiano,L.,Gueresi,P.,Passeri,G.,Berardelli,M.,Prolisso,G.,Barbieri,M.,Tesei,S.,Lisa,R.,De Benedictis,G.,Franceschi,C.,2002.Genetic analysis of Paraoxonase(PON1)locus reveals an increased frequency of Arg192 allele in centenarians.Eur.J.Hum.Genet.10,292-296
    [55]Marchegiani,F.,Marra,M.,Spazzafumo,L.,James,R.W.,Boemi,M.,Olivieri,F.,Cardelli,M.,Cavallone,L.,Bonfigli,A.R.,Franceschi,C.,2006.Paraoxonase activity and genotype predispose to successful aging.J.Gerontol.A:Biol.Sci.Med.Sci.61,541-546
    [56]Candore,G.,Balistreri,C.R.,Grimaldi,M.R,Listi,R,Vasto,S.,Caruso,M.,Caimi,G.,Hoffmann,E.,Colonna-Romano,G.,Lio,D.,Paolisso,G.,Franceschi,C.,Caruso,C.,2006.Opposite role of pro-inflammatory alleles in acute myocardial infarction and longevity:results of studies performed in a Sicilian population.Ann.N.Y.Acad.Sci.1067,270-275
    [57]Scola,L.,Candore,G.,Colonna-Romano,G.,Crivello,A.,Forte,G.I.,Prolisso,G.,Franceschi,C.,Lio,D.,Caruso,C.,2005.Study of the association with 330T/GIL-2 in a population of centenarians from centre and south Italy.Biogerontology 6,425-429
    [58]Franceschi,C.,Bonafe,M.,2003.Centenarians as a model for healthy aging.Biochem.Soc.Trans.31,457-461
    [59]Conboy,I.M.,Rando,T.A.,2005.Aging,stem cells and tissue regeneration:lessons from muscle.Cell Cycle 4,407-410
    [60]Bagnara,G.P.,Bonsi,L.,Strippoli,P.,Bonifazi,F.,Tonelli,R.,D'Addato,S.,Paganelli,R.,Scala,E.,Fagiolo,U.,Monti,D.,Cossarizza,A.,Bonafe,M.,Franceschi,C.,2000.Hemopoiesis in healthy old people and centenarians:well-maintained responsiveness of CD34+ cells to hemopoietic growth factors and remodeling of cytokine network.J.Gerontol.A:Biol.Sci.Med.Sci.55,B61-B66.
    [61]Bonafe,M.,Salvioli,S.,Barbi,C.,Trapassi,C.,Tocco,F.,Storci,G.,Invidia,L.,Tannini,I.,Rossi,M.,Marzi,E.,Misto,M.,Capri,M.,Olivieri,F.,Antonicelli,R.,Memo,M.,Uberti,D.,Nacmias,B.,Sorbi,S.,Monti,D.,Franceschi,C 2004.The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death.Cell Death Differ.11,962-973
    [62]Rose,G.,Passarono,G.,Carrieri,G.,Altomare,K.,Greco,V.,Bertolini,S.,Bonafe,M.,Franceschi,C.,De Benedictis,G.,2001.Paradoxes in longevity:Sequence analysis of mtDNA haplogroup J in centenarians.Eur.J.Hum.Genet.9,701-707
    [63]Perretti,M.,D'Acquisto,F.,2006.Novel aspects of annexin 1 and glucocorticoid biology:intersection with nitric oxide and the lipoxin receptor.Inflanim.Allergy Drug Targets 5,107-114
    [64]Tumbull,A.V.,Rivier,C.L.,1999.Regulation of the hypothalamic-pituitaryadrenal axis by cytokines:actions and mechanisms of action.Physiol.Rev.79(1 71),1999
    [65]Banks,W.A.,Kastin,A.J.,Broadwell,R.D.,1995.Passage of cytokines across the blood-brain barrier.Neuroimmunomodulation 2,241-248
    [66]Tieri,P.,Valensin,S.,Latora,V.,Castellani,GC,Marchiori,M.,Remondini,D.,Franceschi,C.,2005.Quantifying the relevance of different mediators in the human immune cell network.Bioinformatics 21,1639-1643

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700